Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine Round Up 2025 Budget'24
  • Budget'25 Budget'24
    • Home
    • News
    Zomato expects a block deal as Antfin Singapore likely sells its share

    Zomato expects a block deal of Rs 5,438.50 crore as Antfin Singapore likely sells its share


    Finance Outlook India Team | Tuesday, 20 August 2024

    Food aggregator Zomato's shares were sold in a block auction on August 20 for Rs 5,438.50 crore, which was later increased, with Antfin Singapore Holding, an Alibaba Group affiliate, the likely seller.

    The block sale involved the transfer of up to 21 crore shares, representing a 2.4 percent ownership in the online meal delivery company. The deal was finalized at a floor price of Rs 258 per share, representing a nearly 2% discount over the stock's previous closing price.

    Following the block deal, Zomato shares experienced a knee-jerk response and plummeted more than 1%. At 09.21 a.m., the shares were trading at Rs 259.20 on the NSE. While Moneycontrol could not immediately identify the parties involved in the deal, CNBC-TV18 reported on August 19 that Antfin Singapore Holding was looking to sell a 2% share in Zomato for $556 million (Rs 4,650 crore).

    Antfin previously announced plans to sell 1.54 percent of its stock for $408 million. According to Zomato's most recent ownership statistics, Antfin Singapore Holding owns a 4.3% interest in the meal delivery business. The share sale will also result in a 90-day lock-in period before Antfin may carry out another round of stock dilution.

    The equity sale comes on the wake of Zomato's quarterly reports, which increased net profit by 126.5 times to Rs 253 crore in the April-June quarter compared to the same period last year. Profit growth was driven by higher platform fees paid to customers and greater operational profitability in its rapid commerce unit, Blinkit.

    Furthermore, Zomato's quarterly success and strong development potential in sectors such as rapid commerce prompted positive price targets and boosted shares by roughly 20% in only the last month.

    The stock has also been a multi-bagger, with investors receiving gains of 112 percent year to date and over 200 percent over the last year. Some brokerages, such as CLSA and UBS Securities, expect the stock to reach Rs 300 within the next year, further increasing gains.



    Read More:

    Piyush Goyal Announces Rs 10,000 Crore Fund of Funds for Startups

    Ashika Institutional, MOFSL & Bajaj Broking Markets Closing Commentary

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe About Us